Generated by GPT-5-mini| Jacobs Institute | |
|---|---|
| Name | Jacobs Institute |
| Formation | 2009 |
| Type | Research institute |
| Headquarters | Buffalo, New York |
| Region served | United States |
| Leader title | CEO |
| Leader name | Paul A. Lewandowski |
Jacobs Institute The Jacobs Institute is an independent biomedical research and training center focused on vascular disease treatment and medical device innovation. Founded by philanthropists associated with the Jacobs family and linked to clinical partners in Western New York, the Institute operates at the interface of translational research, device testing, and physician education. It collaborates with academic centers, industry partners, and government agencies to accelerate novel therapies into practice.
The Institute was established in 2009 with support from the Ernest G. and Julia S. Jacobs Foundation and local healthcare leaders in Buffalo, New York. Early initiatives grew from collaborations with the State University of New York at Buffalo and the University at Buffalo Jacobs School of Medicine and Biomedical Sciences, leveraging expertise from faculty engaged with the American Heart Association, Society for Vascular Surgery, and interventional teams affiliated with the Catholic Health system. Over its first decade, the organization hosted programs endorsed by the U.S. Food and Drug Administration, partnered with device firms such as Medtronic, Boston Scientific, and Abbott Laboratories, and worked alongside trial networks including NIH Clinical Center collaborators and multicenter consortia.
The Institute’s mission emphasizes translational medicine, clinician training, and device evaluation for cerebrovascular and peripheral vascular disease. Programmatic offerings include hands-on courses linked to the American College of Cardiology, live-case demonstrations with teams from Cleveland Clinic, and fellowship support associated with the American Board of Internal Medicine pathways. It runs industry-funded workshops with partners like Stryker Corporation, Terumo Corporation, and Johnson & Johnson subsidiaries while aligning with quality initiatives promoted by the Joint Commission and accreditation standards from the Accreditation Council for Graduate Medical Education.
Research at the Institute spans preclinical device testing, clinical trial facilitation, and outcomes research in stroke, aneurysm, and peripheral arterial disease. Investigations have connected investigators from the National Institutes of Health ecosystem, collaborators at the Mayo Clinic, and engineering groups from the Massachusetts Institute of Technology. Device development projects have drawn on expertise from startups mentored by Plug and Play Tech Center-style incubators and corporate R&D units including GE Healthcare and Philips Healthcare. The Institute has supported trials registered through networks working with the ClinicalTrials.gov platform and has published outcome analyses in journals associated with the American Heart Association and the European Society of Cardiology.
Clinical partnerships link the Institute with tertiary care centers such as the Kaleida Health system and specialty programs at the Roswell Park Comprehensive Cancer Center for vascular access strategies in oncology. Educational activities include simulation training endorsed by the Society for Neuroscience and procedural skill labs modeled after courses from the European Stroke Organisation and the World Federation of Interventional and Therapeutic Neuroradiology. Visiting faculty have included clinicians affiliated with Mount Sinai Health System, the University of California, San Francisco, and the Johns Hopkins Hospital, while continuing medical education credits have been coordinated with bodies like the Accreditation Council for Continuing Medical Education.
Situated in an innovation campus in Buffalo, the Institute’s facilities contain catheterization laboratory simulators, benchtop flow models, and hybrid procedure suites comparable to those at the Mayo Clinic Hospital. Infrastructure supports collaboration with engineering partners at institutions such as the Rochester Institute of Technology and Cornell University. The center maintains data capture and analytics capacity that interoperates with clinical information systems used at Kaleida Health and leverages imaging resources similar to those at the Memorial Sloan Kettering Cancer Center for vascular imaging research.
Funding sources include philanthropic gifts from the Jacobs family, grants from the National Institutes of Health, industry-sponsored research agreements with corporations such as Medtronic and Boston Scientific, and support from regional development entities like the Empire State Development Corporation. Governance comprises a board with representatives from academic partners University at Buffalo, industry advisors from Johnson & Johnson, and clinical leaders from systems including Catholic Health and Kaleida Health. Financial oversight practices reflect nonprofit standards used by institutions like the Robert Wood Johnson Foundation and reporting frameworks similar to those of the IRS for tax-exempt entities.
Category:Medical research institutes in the United States